Status: Recruiting
Autologous Serum Eye Drops in Dry Eye Syndrome
This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to conventional artificial tear therapy.
Participants needed: 70
Trial details
Age: Up to 18Biological sex: AllType: InterventionalSponsor: The General Authority for Teaching Hospitals and InstitutesUpdated: Dec 22, 2025Locations: 1
Eligibility criteria
Children aged less than 18 years. [+2]
Active ocular infection. [+3]